Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
|Articles|July 2, 2020
- Pharmaceutical Technology-07-02-2020
- Volume 44
- Issue 7
Double Planetary Mixer
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system. The sanitary four-gallon Double Planetary Mixer & Discharge System Model DPM/DS-4S (pictured) includes interior and exterior stainless-steel, and type 316 surfaces with an electropolished, 150-grit finish. The mixer’s jacketed mixing vessel and high viscosity blades are equipped to produce thick gels, pastes, putties, and other semi-solids under specific temperatures, and its sealed gearbox and stirrer shafts help ensure complete cleanability and eliminate cross-contamination between batches.
Articles in this issue
over 6 years ago
Performing Remote Audits During the Pandemicover 6 years ago
Demand for Custom Dosage Forms Fuels Innovationover 6 years ago
Learning Regulatory Lessons in Times of a Crisisover 6 years ago
Business on Hold? EMA’s Full Recovery in Questionover 6 years ago
Taking a Controlled Approachover 6 years ago
Unprecedented Times in Vaccinesover 6 years ago
No Business, Like Brexit Businessover 6 years ago
Innovating Continuous Twin-Screw Granulation with Foam DeliveryRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5